15 Startling Facts About Fentanyl Citrate Injection Formulations UK You Didn't Know

May 19, 2026

Understanding Fentanyl Citrate Injection Formulations in the UK: A Clinical Overview

Fentanyl citrate remains among the most vital tools in modern anaesthesia and severe discomfort management throughout the United Kingdom. As a powerful artificial opioid, its function in the National Health Service (NHS) and personal surgical sectors is well-established, mostly due to its rapid start of action and cardiovascular stability. read more offers a comprehensive overview of fentanyl citrate injection solutions readily available in the UK, their medical signs, regulatory landscape, and administration procedures.

What is Fentanyl Citrate?

Fentanyl citrate is a powerful phenylpiperidine-derivative opioid agonist. It was very first manufactured in 1960 and quickly became a cornerstone of perioperative care. In terms of effectiveness, fentanyl is around 50 to 100 times more potent than morphine. Its high lipophilicity enables it to cross the blood-brain barrier rapidly, causing a nearly immediate analgesic impact when administered intravenously.

In the UK, fentanyl citrate is predominantly used via the parenteral route (injection) for both sedative and analgesic purposes. It works mostly by binding to the mu-opioid receptors in the main worried system, altering the understanding of discomfort and the emotional response to it.

Medical Indications in the UK

According to the British National Formulary (BNF), fentanyl citrate injection is shown for several particular clinical scenarios:

Analgesic Action: Used during brief personnel treatments and in the healing space.
Analgesic Supplement: Used during the induction and maintenance of inhalation anaesthesia.
Neuroleptanalgesia: Often used in mix with a neuroleptic (such as droperidol) to attain a state of quiescence and decreased awareness.
Management of Severe Pain: Particularly in the Intensive Care Unit (ICU) for patients on mechanical ventilation.
Pre-medication: To provide sedation and analgesia before the induction of general anaesthesia.

Offered Formulations and Strengths in the UK

The UK market uses a number of solutions of fentanyl citrate, developed to satisfy the varying needs of surgical and emergency situation departments. These are typically presented as clear, colourless solutions for injection or infusion.

Table 1: Common Fentanyl Citrate Formulations in the UK

Strength (Fentanyl base)

Presentation

Common Packaging

Manufacturer Examples

50 micrograms/ml

2 ml Ampoule

Pack of 10

Hameln, Advanz Pharma

50 micrograms/ml

10 ml Ampoule

Load of 5 or 10

Hameln, Wockhardt

50 micrograms/ml

20 ml Vial/Ampoule

Pack of 5

Hameln, Generic

50 micrograms/ml

50 ml Vial

Individual/Pack of 1

Generic (ICU usage)

Note: While 50 mcg/ml is the standard concentration, specialised formulas for epidural or intrathecal usage may in some cases be prepared by medical facility drug stores under specific protocols.

Pharmacokinetics and Pharmacodynamics

Understanding how the body processes fentanyl is crucial for safe administration.

Onset of Action: When administered intravenously, the effect begins nearly right away, though the optimum analgesic effect may take 3 to 5 minutes.
Period: A single intravenous dose of 100 micrograms typically lasts for 30 to 60 minutes.
Metabolic process: Fentanyl is mainly metabolised in the liver via the CYP3A4 enzyme system.
Excretion: Approximately 75% of the dose is excreted in the urine within 24 hours, mainly as metabolites.

Administration Protocols

In the UK, the administration of fentanyl citrate is strictly controlled and typically performed by anaesthetists or trained practitioners in regulated environments.

Dosage Guidelines

Dose needs to be horizontal and individualised based on the client's age, weight, physical status, underlying pathological condition, use of other drugs, and the kind of surgical treatment.

Low Dose (2 mcg/kg): Useful for minor surgeries.
Moderate Dose (2— 20 mcg/kg): Used when surgery is more intrusive; needs respiratory monitoring.
High Dose (20— 50 mcg/kg): Used throughout “worry-free” significant surgeries (e.g., open-heart surgical treatment) to safeguard the myocardium from the metabolic needs of tension.

Routes of Administration

Intravenous (IV) Bolus: Common for induction.
Intravenous Infusion: Used for longer treatments or in the ICU.
Intramuscular (IM): Less common, however utilized for pre-medication in particular situations.

Regulative Status and Safety

In the United Kingdom, Fentanyl is categorized under the Misuse of Drugs Act 1971 as a Class A drug. Under the Misuse of Drugs Regulations 2001, it is categorized as a Schedule 2 Controlled Drug (CD POM).

Statutory Requirements for UK Hospitals:

Safe Custody: Must be kept in a locked controlled drug cupboard.
Record Keeping: Every administration must be tape-recorded in a Controlled Drugs Register (CDR).
Destruction: Surplus or ended fentanyl should be denatured and experienced by authorised workers.

Negative Effects and Adverse Reactions

While extremely reliable, fentanyl citrate carries a danger of considerable adverse effects.

Breathing Depression: The most serious negative effects, which can lead to respiratory arrest if not monitored.
Bradychardia: Often managed with atropine.
Muscle Rigidity (Chest Wall Rigidity): High doses can make ventilation hard, needing making use of neuromuscular blocking representatives.
Nausea and Vomiting: Common in the postoperative period.
Hypotension: Although more stable than morphine, it can still happen, particularly in hypovolaemic patients.

Comparison with Other Opioids

Clinicians typically choose fentanyl over other opioids due to its particular pharmacokinetic profile.

Table 2: Comparison of Parenteral Opioids in UK Practice

Function

Fentanyl

Morphine

Remifentanil

Relative Potency

100

100-200

Start

1— 3 minutes

15— 30 minutes

1 minute

Duration of Action

30— 60 minutes

3— 4 hours

5— 10 minutes

Histamine Release

Minimal

Substantial

Minimal

Main Use

Intraoperative/ICU

Post-operative/Chronic

Titratable Infusion

Often Asked Questions (FAQ)

1. Is fentanyl citrate injection the like the fentanyl patches?

No. While they consist of the very same active drug, the injection is for instant, acute use in surgical or emergency situation settings. Patches (transdermal delivery) are developed for persistent, long-lasting pain management and launch the medication gradually over 72 hours.

2. Can fentanyl citrate be utilized for kids in the UK?

Yes, it is often utilized in paediatric anaesthesia. Nevertheless, the dosage should be strictly calculated based upon the kid's weight, and they need to be kept an eye on carefully for respiratory anxiety.

3. What is the villain for fentanyl?

Naloxone is the particular pharmacological antagonist used to reverse the impacts of fentanyl, including respiratory anxiety. In UK health centers, naloxone must constantly be easily available any place fentanyl is administered.

4. Why is it used over morphine in heart surgery?

Fentanyl is preferred in heart surgical treatment due to the fact that it does not cause the release of histamine, which can lead to vasodilation and hypotension. It provides cardiovascular stability even at high doses.

5. What are the storage requirements?

Fentanyl citrate injection ought to be kept listed below 25 ° C and safeguarded from light. As a Schedule 2 drug, it should be kept in a legally certified CD cupboard.

Fentanyl citrate injection formulas are vital components of the UK's medical toolkit for handling perioperative discomfort and facilitating complicated surgeries. Its high potency and rapid onset deal unmatched precision for anaesthetists, offered that strenuous monitoring and regulative requirements are maintained. By comprehending the different concentrations and the strict protocols surrounding its use, healthcare specialists ensure that this powerful medication remains both safe and efficient for patients across the nation.

Disclaimer: This post is for educational functions only and does not make up medical suggestions. Healthcare professionals must always refer to the Summary of Product Characteristics (SmPC) and present BNF guidelines for the most current recommending details.